Metagenics PainX
Directions: Metagenics PainX
Adults: Add 1 scoop (5 g) to 200 mL water twice daily.
Dosing – The daily dosage of PEA in clinical trials has ranged from 300mg–1200mg daily for chronic pain and up to 1800mg daily for acute colds and flu. Clinical trial data would suggest that a loading dose of 600–1200mg for 3–4 weeks followed by a maintenance dose of 300–600mg may be the most appropriate dosing strategy for chronic pain conditions. Individual requirements will vary.
Timing – Considering that PEA is a fat soluble compound, consumption with a fat-containing meal may enhance absorption.
Contraindications and adverse effects – There are no known contraindications. PEA has been clinically studied across a broad population group and has been found to be highly tolerable, with aside effect profile similar to placebo.
Why is there a 21-Day Warning for Bio Absorb PEA? Is it safe to take long term?
The Therapeutic Goods Association (TGA) mandates a 21-day warning be placed on all listed PEA product labels. In listing this medicine, 17 clinical studies were provided to the TGA, of these, only three were conducted in ‘healthy participants’ with the maximum duration of these studies being 21 days, hence these three studies were considered by the TGA.
Numerous other studies exist which used PEA over three months without negative effects. See references Tab for 256 references relating to PEA.
Always read the label. Use only as directed. If symptoms persist consult your healthcare professional.
Benefits: Metagenics PainX
Key Clinical Applications:
- Low back pain
- Muscle cramps and spasms
- Chronic jaw pain
- Migraine/headache
- Fibromyalgia
Relieves neuromuscular pain: Magnesium exerts muscle-relaxing actions (and prevents muscle spasms) via multiple mechanisms and is a natural glutamate antagonist.1 Glutamate is involved in central sensitisation and pain amplification.2 Magnesium regulates neuromuscular transmission by blocking the entry of calcium ions in synaptic nerve terminals,3 as well as inhibiting presynaptic acetylcholine release, which propagates impulses between motor nerves and muscles.4
Higher magnesium intake has found to be protective against chronic pain.5 However, one third of Australian adults fail to meet their requirements for adequate magnesium intake.6 PainX contains 420 mg/d to support adults to meet the recommended intake of 310 to 320 mg/d in women and 400 to 420 mg/d in men.7
Figure 1: Magnesium and PEA Address Multiple Drivers of Pain Amplification.
Palmitoylethanolamide (PEA) promotes endogenous cannabinoid system (ECS) activity through its ability to augment the activity of cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2).8
These receptors are expressed in nerve tissue and immune cells and are involved in modulating the inflammatory response by suppressing immune cell activation, which can reduce pain perception.9 PEA proves to be effective and safe in nerve compression syndromes. In one pivotal, double blind, placebo-controlled trial in 636 sciatic pain patients, subjective pain scores were reduced from 6.5/10 to 3.6/10 in the 300 mg/d group, while in the 600 mg/d group scores were reduced from 7.1/10 to 2.1/10 compared to placebo, which decreased from 6.6/10 to 4.6 (Figure 2).10
Figure 2: Outcomes of 600 mg/d of PEA on Sciatic Pain.
Meta Mag and Levagen+ are both exclusive types of magnesium and PEA, respectively, that show enhanced bioavailability.11 Meta Mag is different to magnesium salts and other magnesium chelates because it is covalently bound to two glycine molecules.12 Levagen+ is a highly bioavailable PEA using LipiSperse technology for enhanced absorption.13 The Levagen+ absorption studies show that Levagen+ is 1.7 times better absorbed and that it stays in the plasma for a longer period of time compared to a standard PEA (Levagen) (Figure 3). Clinically, 600 mg/d of Levagen+ PEA is likely to equate to consuming 1,000 mg/d of a standard micronised PEA (Levagen). A Practitioner can expect Levagen+ to produce greater efficacy and to last longer in the body.14
Figure 3: Levagen+ PEA vs Standard PEA
Levagen+ is owned by Gencor Pacific Limited.
Meta Mag is a registered trademark of Balchem Corp
Ingredients: Metagenics PainX
Each dose (5 g) of PainX contains: | |
Magnesium glycinate dihydrate | |
(Meta Mag - Magnesium bisglycinate) | 2.1g |
equivalent Magnesium | 210mg |
Palmidrol (Palmitoylethanolamide) (Levagen+) | 300mg |
PainX contains 750 mg of malic acid per dose.
Excipients: Metagenics PainX
PainX contains 750 mg of malic acid per dose.
Allergen Advice: Metagenics PainX
Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts, yeast and soy protein.
Warnings: Metagenics PainX
This medicine is not to be used for more than 21 consecutive days, and may interact with other prescription analgesic medicines.
Please consult your healthcare Practitioner before use.
Suitable for individuals 18 years and over.
Mineral supplements should not replace a balanced diet.
Not all cautions and contraindications are listed. For full details, references or more information contact HealthMasters in Australia by email: reception@healthmasters.com.au.
Why is there a 21-Day Warning for Bio Absorb PEA? Is it safe to take long term?
The Therapeutic Goods Association (TGA) mandates a 21-day warning be placed on all listed PEA product labels. In listing this medicine, 17 clinical studies were provided to the TGA, of these, only three were conducted in ‘healthy participants’ with the maximum duration of these studies being 21 days, hence these three studies were considered by the TGA.
Numerous other studies exist which used PEA over three months without negative effects. See references Tab for 256 references relating to PEA.
Always read the label. Use only as directed. If symptoms persist consult your healthcare professional.
Storage: Metagenics PainX
Store below 30°C